Dimethyl sulfoxide enhances effectiveness of skin antiseptics and reduces contamination rates of blood cultures

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1552-1557

  Tarrand, Jeffrey J ^a   LaSala, Paul R ^a   Han, Xiang Yang ^a   Rolston, Kenneth V ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PROPANOL; ANTIINFECTIVE AGENT; DIMETHYL SULFOXIDE; IODINE;

ACINETOBACTER BAUMANNII; ANTISEPSIS; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BLOOD CULTURE; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS EPIDERMIDIS;

2-PROPANOL; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; BACTERIAL LOAD; BLOOD; DIMETHYL SULFOXIDE; DRUG SYNERGISM; FEMALE; HUMANS; IODINE; MALE; MICROBIAL VIABILITY; MIDDLE AGED; SKIN; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 84860004857     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05106-11     Document Type: Article

References (29)

1. Bates DW, Goldman L, Lee TH. 1991. Contaminant blood cultures and resource utilization: the true consequences of false-positive results. JAMA 265:365-369.
2. Bekeris LG, Tworek JA, Walsh MK, Valenstein PN. 2005. Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions. Arch. Pathol. Lab. Med. 129:1222-1225. (Pubitemid 41407424)
3. Boyce JM. 2004. New insights into improving hand hygiene practices. Infect. Control Hosp. Epidemiol. 25:187-188. (Pubitemid 38339619)
4. Boyce JM. 2001. Antiseptic technology: access, affordability, and acceptance. Emerg. Infect. Dis. 7:231-233. (Pubitemid 32374334)
5. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee Hand Hygiene Task Force. 2002 Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHES/APIC/ IDSA Hand Hygiene Task Force. Am. J. Infect. Control 30:S1-S46. (Pubitemid 36009085)
6. Centers for Medicare and Medicaid Services. 14 March 2012, accession date. Quality of care measure specifications: surgical infection prevention. Centers for Medicare and Medicaid Services, Baltimore, MD. http://www .cms.hhs.gov/hospitalqualityinits/01-overview.asp.
7. Coltron T. 1974. Statistics in medicine. Little Brown & Co., Boston, MA.
8. Cruse PJE, Foord R. 1980. The epidemiology of wound infection: a 10 year prospective study of 62,939 wounds. Surg. Clin. North Am. 60:27-40. (Pubitemid 10049641)
9. Culver DH, Horan TC, Gaynes RP. 1991. Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am. J. Med. 91:152S-157S.
10. Darouiche RO, et al. 2010. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N. Engl. J. Med. 362:18-26.
11. Dhillon RH, Clark J, Azadian BS. 2009. Reducing blood culture contamination. J. Hosp. Infect. 73:97-99.
12. DiPiro JT, et al. 1998. Infection in surgical patients: effects on mortality, hospital stay, and postdischarge care. Am. J. Health Syst. Pharmacol. 55: 777-781.
13. Fry DE. 2002. The economic costs of surgical site infections. Surg. Infect. (Larchmt.) 3(Suppl 1):S37-S43.
14. Gander RM, et al. 2009. Impact of blood cultures drawn by phlebotomy on contamination rates and health care costs in a hospital emergency department. J. Clin. Microbiol. 47:1021-1024.
15. Geesey GG, White DC. 1990. Determination of bacterial growth and activity at solid-liquid interfaces. Annu. Rev. Microbiol. 44:579-602.
16. Green JW, Wenzel RP. 1997. Postoperative wound infection. A controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann. Surg. 185:264-268.
17. Hall MJ, Owings MF. 2002. 2000 National hospital discharge survey. Adv. Data 19:1-18.
18. Joklik WJ, Willett HP. 1992. Sterilization and disinfection, p 188-199. In Joklik WJ, Willett HP, Amos DB, and Wilfert CM (ed), Zinsser microbiology, 20th ed. Appleton & Lange, Norwalk, CT.
19. Notman R, Noro M, O'Malley B, Anwar J. 2006. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. J. Am. Chem. Soc. 128:13982-13983. (Pubitemid 44657463)
20. Strand C, Shulman JA. 1988. Bloodstream infections: laboratory detection and clinical considerations. ASCP Press, Chicago, IL.
21. Tarrand JJ, et al. 1991. Clinical comparison of the resin-containing Bactec 26 Plus and the Isolator 10 blood culturing systems. J. Clin. Microbiol. 29:2245-2249.
22. Tarrand JJ, Groschel DHM. 1982. Rapid modified oxidase test for oxidase- variable bacterial isolates. J. Clin. Microbiol. 16:772-774. (Pubitemid 12029319)
23. Trautner BW, Clarridge JE, Darovich RO. 2002. Skin antisepsis kits containing alcohol and chlorhexidine gluconate or tincture of iodine are associated with low rates of blood culture contamination. Infect. Control Hosp. Epidemiol. 23:397-401. (Pubitemid 34831384)
24. Urban JA. 2006. Cost analysis of surgical site infections. Surg. Infect. 7(Suppl 1):S19-S22.
25. Vlassova N, Han A, Zenilman JM, James G, Lazarus GS. 2011. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br. J. Dermatol. 165:751-759.
26. Weinstein M, Carroll KC. 2007. Manual and automated systems for detection and identification of microorganisms, p 194. In Murray PR, et al (ed), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
27. Weinstein MP. 2003. Blood culture contamination: persisting problems and partial progress. J. Clin. Microbiol. 41:2275-2278. (Pubitemid 36712422)
28. Willson JE, Brown DE, Timmens EK. 1965. A toxicologic study of dimethyl sulfoxide. Toxicol. Appl. Pharmacol. 7:104-112.
29. Zoutman D, McDonald S, Velhanayagan D. 1998. Total and attributable costs of surgical wound infections at a Canadian tertiary-care center. Infect. Control Hosp. Epidemiol. 19:254-259. (Pubitemid 128472672)